CD274 and neoplasm: The PD-1/PD-L1 signaling cascade is an inhibitory factor in the cancer-immunity cycle.28 PD-L1 expression is thus assessed on both tumor-infiltrating immune cells (TIICs) and TCs for its predictive value.